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Abstract
Objective—The APOA2 gene has been associated with obesity and insulin resistance (IR) in
animal and human studies with controversial results. We have reported an APOA2-saturated fat
interaction determining body mass index (BMI) and obesity in American populations. This work
aims to extend our findings to European and Asian populations.
Methods—Cross-sectional study in 4602 subjects from 2 independent populations: A high
cardiovascular risk Mediterranean population (n=907 men and women; aged 67+/−6 years) and a
multiethnic Asian population (n=2506 Chinese, n=605 Malays and n=494 Asian Indians; aged
39+/−12 years), participating in a Singapore National Health Survey. Anthropometric, clinical,
biochemical, lifestyle and dietary variables were determined. Homeostasis model assessment of IR
(HOMA-IR) was used in Asians. We analyzed gene-diet interactions between the APOA2
−265T>C polymorphism and saturated fat intake (<or>=22 g/d) on anthropometric measures and
IR.
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Results—Frequency of CC subjects differed among populations (1%–15%). We confirmed a
recessive effect of the APOA2 polymorphism, and replicated the APOA2–saturated fat interaction
on body-weight. In Mediterranean individuals, the CC genotype was associated with a 6.8%
greater BMI in those consuming a high (P=0.018), but not a low (P=0.316) saturated fat diet.
Likewise, the CC genotype was significantly associated with higher obesity prevalence in Chinese
and Asian Indians only with a high-saturated fat intake (P=0.036). We also found a significant
APOA2-saturated fat interaction in determining IR in Chinese and Asian Indians (P=0.026).
Conclusion—The influence of the APOA2 −265T>C polymorphism on body-weight-related
measures was modulated by saturated fat in Mediterranean and Asian populations.
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Obesity; gene-diet interaction; insulin resistance; saturated fat; APOA2
INTRODUCTION
For over two decades, the search for the genetic background underlying common forms of
obesity has yielded scores of associations that, for the most part, could not be successfully
validated in replication studies (1). Genome-wide association (GWA) studies have led to the
discovery of new obesity genes (2–4). Among them, the obesity-associated gene (FTO) has
now become the first gene with associations thoroughly replicated (2,5,6). Nevertheless,
common interactions with environmental factors may have contributed to mask the effect of
other single nucleotide polymorphisms (SNPs) on obesity (7). Progress in the investigation
and replication of gene-environment interactions for obesity has been slow. However, some
steps forward have been accomplished, such as those involving the FTO with physical
activity (8–10), and the APOA2 with saturated fat intake (11). In both cases, significant
interactions were found and replicated in independent populations. Regarding the APOA2
locus, several associations with obesity, insulin-resistance (IR) and diabetes have been
reported both in animal (12–15) and human studies (16–18). Specifically, the −265T>C
promoter polymorphism (rs5082), which has proved to be functional in two independent
investigations (19,20), has been significantly associated with obesity-related measures in
some human studies (11,19,21–23). In a previous investigation carried out on White
Americans participating in the Genetics of Lipid Lowering Drugs and Diet Network
(GOLDN) study (21), we observed recessive effects for the −265T>C polymorphism.
Homozygous individuals for the −265C allele had higher body mass index (BMI) and
obesity risk than did carriers of the T allele. However, we did not find significant
associations between this SNP and body-weight measures in the Framingham Study or in the
Boston Puerto Rican study, but we did find significant interactions between this SNP and
saturated fat intake (11). When saturated fat intake was high (higher than 22 g/d; approx
10% of energy), individuals homozygous for the −265C allele had higher mean BMI than
carriers of the T allele (an association which was statistically significant), but no differences
in BMI were found when saturated fat intake was low.
Therefore, our objectives were to extend previous findings by: 1) analyzing the association
between the APOA2 −265T>C SNP and body-weight-related variables in a Mediterranean
and in a multiethnic Asian population; 2) examining the replication of the previously
reported interaction between this SNP and saturated fat intake on body-weight in these
populations and 3) exploring the association of this SNP with IR and diabetes and its
potential modulation by saturated fat.
Corella et al. Page 2
Int J Obes (Lond). Author manuscript; available in PMC 2011 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
PATIENTS AND METHODS
We analyzed 4,602 subjects from two independent populations. All participants gave their
informed consent. The ethics committee of the University of Valencia and the ethics
committee of the Singapore General Hospital approved the studies.
Mediterranean population
We studied 907 unrelated Whites (325 men and 582 women), aged 55–80 years who
participated in the PREDIMED (Prevención con Dieta Mediterránea) study and were
consecutively recruited in the Valencia Region (Spain) from October 2003 to September
2008. Details of this study have been reported elsewhere (24). Briefly, high-risk participants
were selected by physicians in primary care centers. Eligible subjects were elderly
community-dwelling persons who fulfilled at least 1 of 2 criteria: type 2 diabetes or 3 or
more cardiovascular disease risk factors (current smoking, hypertension, dyslipidemia,
overweight, or a family history of premature cardiovascular disease). Here, we included data
from the baseline cross-sectional examination.
Asian population
We studied 3,695 individuals (1,714 males and 1,981 females) who participated in the 1998
Singapore National Health Survey and had genetic data. The detailed methodology of this
survey on a nationally representative household sample has been described elsewhere (25).
Briefly, the survey protocol was based on the WHO-recommended model for field surveys
on diabetes and the WHO MONICA protocol. Individuals representing the Singapore
housing population (Chinese, Malays and Indians) aged 18–69 years were selected by
disproportionate stratified and systematic sampling. Dietary intake was only assessed in a
random sub-sample (1 in 2) of the participants. In the present study, dietary data were
available for 1,923 subjects (1,204 Chinese, 412 Malays and 307 Asian Indians). These
subjects did not differ in the main variables examined from subjects without dietary data.
Anthropometric, biochemical, clinical and lifestyle determinations
Anthropometric variables including height, weight and waist were measured in both
populations by standard techniques (24,25). Body mass index (BMI) was calculated as
weight (kg)/height2(m). Obesity was defined as BMI>=30kg/m2 for the Mediterranean
population and as BMI>=27kg/m2 for the Asian population (26,27). Fasting triglycerides
and HDL-C were measured by standard methods (24,25). In the Asian population, fasting
glucose (Boehringer Manheim, Mannheim, Germany) and fasting insulin (immunoassay
using an Abbott AxSYM; Abbott Laboratories, Chicago, IL) were determined in all
participants (25). IR (fasting glucose × fasting insulin/22.5) was calculated using the
homeostasis model assessment of insulin resistance (HOMA-IR) method (28), as a
biomarker for IR. In the Asian population, previously diagnosed diabetes was assessed by
questionnaire (25). After the fasting sample collection, a 75-g oral glucose tolerance test was
taken for all subjects except for previously diagnosed diabetic subjects. After 2 h, glucose
(2-h glucose) and insulin (2-h insulin) were measured. Following biochemical
determinations, subjects with fasting glucose ≥126 mg/dL or 2-h glucose ≥200 mg/dL were
also classified as having diabetes (29). In the PREDIMED Study, IR was not determined.
Diagnosis of type 2 diabetes was based on at least one of the following criteria: i) Current
treatment with insulin or oral hypoglycemic drugs; ii) Fasting blood glucose >=126 mg/dl in
two measurements; iii) Casual fasting blood glucose >= 200mg/dl; iv) 2-h glucose >=200
mg/dL (after the oral glucose tolerance test). In the PREDIMED Study, practically all the
diabetic subjects (>99%) had previously been diagnosed by the doctor (based on the above
criteria) before entering the study. However, in the Asian population an important number of
previously unknown diabetes cases (more than 55% of total diabetics) were detected.
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In the PREDIMED Study, the baseline examination included assessment of standard
cardiovascular risk factors, medication use, socio-demographic factors and lifestyle
variables, as previously detailed (24). Physical activity was estimated by the Minnesota
Leisure Time Physical Activity questionnaire (30). In Asians, an interviewer-administered
questionnaire was used to capture data on sociodemographic factors, smoking, alcohol
consumption and physical activity as previously reported (25).
Dietary intake
In the Mediterranean population food consumption and nutrient intake was determined by a
validated food frequency questionnaire (FFQ) (31) and Spanish food composition tables. In
Singapore, a validated FFQ was used (32). It comprised 159 individual food items, grouped
into 23 main food types and 25 food subtypes to ensure that foods consumed by the three
ethnic groups were represented. The food composition database of the Singapore Ministry of
Health was used to estimate macronutrient intake.
Genetic analyses
We performed the APOA2−265T>C genotyping (rs5082) using a Taqman assay with allele-
specific probes in the ABIPrism 7900HT Sequence Detection System (Applied Biosystems)
(21). Quality control measures including positive and negative controls as well as replicated
samples (10% at random) were employed. Genotype frequencies were consistent with
Hardy-Weinberg equilibrium (P=0.10, P=0.79, P=0.59, P=0.20 for Mediterranean subjects,
Chinese, Malays and Asian Indians, respectively).
Statistical analyses
The Chi square test was used to compare proportions. We applied ANOVA or Student’s t-
test to compare crude means. Multivariate adjustment of continuous variables was carried
out by linear regression. Triglycerides and IR were log-transformed. Recessive effects of the
APOA2 SNP were tested and considered in the models. To study gene-diet interactions in
determining BMI and body-weight, we used multivariate linear regression models including
main effects and interaction terms and control for the same variables that we reported in our
previous study (11). We fitted separate models for each population. Saturated fat intake was
considered as categorical (low or high). 22g/d was established as the cut-off point based on
our previous work (11). We adjusted interaction models for sex, age, ethnicity (when
including more than one population), smoking, drinking, diabetes, lipid medication and total
energy intake (basic models). The adjustment for lipid medication was not included in the
Asian populations because this information was not available. Further adjustments of basic
models for physical activity or hypertension were also considered. In addition, adjustment
for total fat, MUFA and carbohydrates were carried out when indicated.
Logistic regression models, including main effects and interaction terms, were fitted to test
the APOA2-SATFAT interaction in determining the odds ratio (OR) of obesity and diabetes.
OR and 95% confidence interval (CI) were estimated for each stratum of saturated fat.
Multivariate adjustments were undertaken as indicated. Standard regression diagnostic
procedures were used to ensure the appropriateness of the fitted models. All reported
probability tests were 2-sided. Differences were considered significant at P <0.05.
RESULTS
Characteristics of the populations
We studied subjects from a Mediterranean and a multiethnic Asian population (Table 1). By
design, Mediterranean subjects were older and had a higher prevalence of cardiovascular
risk factors. In Singapore, prevalence of diabetes was higher in Asian Indians (19.6%).
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Chinese had lower BMI and diabetes. Prevalence of CC subjects was higher in the
Mediterranean population (15%). Saturated fat intake was lower in Chinese. We did not find
significant associations between the APOA2 SNP and saturated fat intake either in Chinese
or Asian Indians, but a borderline significant association was observed in Malays (P=0.08
Fisher exact test). 100% of the Malay CC subjects (n=6) consumed more than 22 g/d of
saturated fat vs 59% in T-allele carriers. In the Mediterranean population, we found a
significant association (P=0.014) in males (84% of the CC males consumed >=22 g/d of
saturated fat vs 65% in T-allele carriers). No significant association was detected in females.
Associations between the APOA2 −265T>C SNP and anthropometric variables
Consistent with our previous findings (11), the effects of this SNP in body-weight were
recessive in both Mediterranean subjects and Asian Indians (Figure 1). No associations were
found in Chinese or Malays (Table 2). In Asian Indians, homozygous CC subjects had
higher means of weight, BMI and waist circumference than T-allele carriers. Prevalence of
obesity (BMI>=27 Kg/m2) was also statistically higher in CC Indian subjects (OR for the
CC in comparison with TT+CT subjects was 3.21; 95%CI: 1.45–7.12, P=0.004), after
multivariate adjustment for sex, age, smoking, drinking and diabetes. Further adjustment for
physical activity did not change the estimation (P=0.005). In the Mediterranean population,
the APOA2 SNP was significantly associated with weight and BMI after multivariate
adjustment for sex, age, smoking, drinking and diabetes. No significant association was
found with waist circumference (P=0.375). Obesity was not significantly associated with the
CC genotype, either unadjusted or after adjustment for sex, age, smoking, drinking and
diabetes (OR: 1.28; 95%CI, 0.83–1.96, P=0.264).
Interactions between the APOA2 −265T>C SNP and saturated fat intake in determining
anthropometric variables
According to the interaction model previously reported (11), two categories of saturated fat
intake were considered (<22g/d and >=22 g/d). In the Mediterranean population (Figure 2
A), we found a statistically significant interaction between the APOA2 SNP and saturated fat
on BMI in the multivariate adjusted model (P for interaction: 0.030). Among those within
the lower saturated fat strata (<22g/d), the APOA2 SNP was not significantly associated with
BMI (P=0.316). In contrast, the CC genotype was associated with greater BMI (P=0.018) in
the higher saturated fat strata. Further adjustment for physical activity, total fat intake,
MUFA and carbohydrates did not change the statistical significance (P: 0.045). In the sub-
group analysis by gender, we found that the magnitude of the interaction was higher in
women than in men. However, taking into account the lower sample size for men, we cannot
confirm differential effects.
In the Asian population, the APOA2-saturated fat interactions were not analyzed in Malays
because there were no CC subjects that had a saturated fat intake lower than 22g/d. Firstly,
the interaction analysis was undertaken in Chinese and Asian Indians jointly (Figure 2B).
Although a greater mean BMI was observed in CC subjects consuming a high saturated fat,
the differences did no reach the statistical significance, and the interaction term between the
APOA2 genotype and saturated fat was not statistically significant (P=0.531). Taking into
account the low prevalence of the CC genotype in Chinese, and the possible heterogeneity of
the effects compared with Asian Indians, we analyzed the APOA2-saturated fat interaction in
Asian Indians. Although the interaction term was not statistically significant (P=0.445), we
observed similar interaction effects to those of the Mediterranean population. A higher
saturated fat intake increased the differences in BMI between the APOA2 genotypes (about
7.1% in the high saturated fat strata: 25.2+/−0.5 Kg/m2 in TT+TC versus 27.1+/−1.2 Kg/m2
in CC; P=0.155 and less than 1% in the low saturated fat: 25.4+/−0.6 Kg/m2 in TT+TC
versus 25.7+/−1.5 Kg/m2 in CC subjects; P =0.758). These results could reflect a lack of
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statistical power due to the small sample size (only 18 CC Indian subjects with dietary data).
Considering our limitations in sample size in the Asian population for detecting as
statistically significant the APOA2-saturated fat interaction in determining the continuous
variable BMI, we focused on the dichotomic variable of obesity (BMI>=27 Kg/m2). For this
analysis, our sample size had sufficient power to detect statistically significant differences.
Consistent with our previous results, we found that the CC genotype was only associated
with a higher OR of obesity in subjects in the high-saturated fat stratum (Table 3). If
saturated fat consumption was low, the CC genotype was not associated with obesity. These
results were statistically significant for Asian Indians and also reached the statistical
significance when the Chinese and Asian Indians were analyzed jointly (OR for obesity in
CC homozygotes: 3.31; 95%CI:1.08–10.18; P=0.036 in the high fat strata).
Association between the APOA2 −265T>C SNP, IR and diabetes. Modulation by saturated
fat intake
In Asian Indians, the APOA2 SNP was significantly associated with higher IR in the
unadjusted analysis (3.7+/−1.9 in CC vs 2.8+/−2.8 in T-allele carriers; P=0.012). No
statistically significant associations were found in Chinese (1.9+/−1.3 in CC vs 1.8+/−1.3 in
T-allele carriers; P=0.611) or in Malays (2.0+/−1.3 in CC vs 2.4+/−2.3 in T-allele carriers;
P=0.484). Next, we tested the APOA2-saturated fat interaction in determining IR in Chinese
and Asian Indians (Figure 3) and found statistically significant results (P for interaction:
0.026). The CC genotype was associated with higher IR only when saturated fat intake was
high (>=22g/d). The APOA2-saturated fat interaction remained statistically significant even
after additional adjustment for BMI (P=0.039).
We further analyzed the association between the APOA2 SNP and diabetes in Chinese and
Asian Indians. In comparison with T-allele carriers, CC subjects had a higher risk of
diabetes (OR: 2.14; 95%CI: 1.01–4.56, P=0.048) after adjustment for sex, age and ethnic
group. However additional adjustment for smoking, drinking and BMI, attenuated the
association (P=0.167). We tested if this association was modulated by saturated fat and
found that, in the low saturated fat strata (<22 g/d), the CC genotype was not associated with
higher diabetes risk (OR: 0.72; 95%CI: 0.08–6.72; P=0.770). However, in the high-saturated
fat strata, the CC genotype was borderline (P=0.080) associated with higher diabetes risk
(OR: 3.10; 95%CI: 0.87–11.02), after adjustment for sex, age, ethnic group, smoking,
drinking and total energy intake. Further adjustment for other macronutrients and physical
activity did not change the statistical significance of results.
In the Mediterranean population, we did not measure IR. In terms of diabetes, the APOA2
SNP was not associated with diabetes in the whole population (P=0.927). However, in
females, prevalence of diabetes was higher in CC women consuming less than 22g/d of
saturated fat (P=0.045), suggesting a potential situation of reverse causation.
DISCUSSION
We have previously reported in three American populations that the APOA2 −265T>C SNP
was associated with BMI or obesity only in the presence of high-saturated fat intake (11).
Our current data are consistent with this gene-diet interaction and extends the findings to
other geographical areas (Europe and Asia). When saturated fat intake is low (<22g/d), this
SNP does not have any effect on BMI or obesity. However, when saturated fat intake is high
(>=22g/d), significant differences in anthropometric variables were detected between CC
individuals and T-allele carriers. Further adjustment for other macronutrients did not change
the significance of our findings, supporting the specificity of saturated fat as a driver of this
interaction.
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Current recommendations to increase the consistency of gene-disease associations underline
the importance of replication in independent samples (33). Our results, supporting the
previous findings on anthropometric variables in the Framingham, the GOLDN and the
Boston-Puerto Rican studies (11), contribute to increase the external validity of this gene-
diet interaction. Moreover, we have reported for the first time a gene-diet interaction
between the APOA2 SNP and saturated fat intake in determining IR in Chinese and Asian
Indians.
The mechanisms behind these novel interactions are still unknown; however, there are some
lines of evidence supporting our findings. APOA2, the second most abundant apolipoprotein
in HDL, plays a complex and relatively undefined role in lipoprotein metabolism, IR,
obesity and atherosclerosis susceptibility (34). Castellani et al (12), found that APOA2
transgenic mice had increased body-weight and body fat content in comparison to control
mice. They also found that overexpression of APOA2 in these mice increased IR as
demonstrated by 2–3 fold higher fasting insulin levels and a delayed clearance of glucose
bolus (12). These results were consistent with the previous observation of Breslow et al (35)
in homozygous APOA2 knockout mice. APOA2 deficiency was associated with lower HDL,
free fatty acid, glucose, and insulin levels, suggesting an insulin hypersensitivity state. More
targeted mechanistic studies using these experimental models have confirmed the role of
APOA2 in IR (13,15,36). However, some controversial results regarding APOA2
overexpression and IR and atherosclerosis have also been reported (34,37,38,39). One of the
sources of discrepancies is that overexpression of human APOA2 in mice does not always
exert effects similar to those of murine APOA2 (38). Interestingly, the other source of
discrepancy and particularly relevant to our findings, is the demonstrated difference in
APOA2 expression depending on the type of diet administered (34,38). Thus, Escola-Gil et
al (39) reported an APOA2-high fat diet interaction in determining the atherosclerotic
effects of the APOA2 transgenic mice. After an atherogenic high-fat (cocoa butter) diet,
human APOA2 transgenic mice developed more extensive aortic atherosclerosis than
control mice. In contrast to the atherogenic diet-fed animals, there was no significant
difference in the area of atherosclerotic lesion when they were fed a regular chow diet.
Taken together, the strong influence of a high-fat diet on the effects of the APOA2 in
transgenic animal models could help to explain our epidemiological gene-diet interaction.
Although the −265T>C SNP has been associated with ~30% drop in basal transcription
activity (19,20) and lower plasma APOA2 concentrations (11) in standard conditions, a
high-saturated fat diet could mask or reverse these effects resulting in a metabolic situation
more favorable to increased body-weight and even IR. One possible hypothesis that we can
suggest for integrating observations on animal and human models would be as follows: The
C allele, associated in general with a lower APOA2 expression would give rise to lower
plasma concentrations of APOA2, found in our previous work (11). If the APOA2 acted as a
satiety signal, as is suggested for the APOA4 (40), a lower plasma APOA2 concentration
would give rise to greater appetite. This appetite would preferably be for foods rich in
saturated fat, and this higher fat intake would lead to greater weight and/or IR. In CC
individuals who did not consume more saturated fat (maintaining it below 22 g/d), no weight
gain or greater susceptibility to IR would be observed.
Previous human studies did not investigate the influence of diet on the effects of the
−265T>C SNP, but controversial results on the association between this SNP and
anthropometric measures have been reported. This SNP has been associated with lower
waist circumference in men (19); with higher abdominal fat depots in women (22); with
higher waist-to-hip ratio in French (23) and with higher BMI in White Americans (21). No
association was also reported (41).
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Type 2 diabetes has been linked to chromosome 1q21–24 in several populations (16–18),
supporting a role for the APOA2 gene (located in 1q23) as a potential candidate; however,
this association is still controversial. A recent case-control cohort comprising 3,093 French
Caucasian subjects, did not find significant association between APOA2 SNPs and type 2
diabetes (23). However, significant gene-gene interactions with SNPs in the adjacent
calsequestrin 1 gene, so increasing diabetes risk, were found in Utah subjects (42). Likewise,
Elbein et al (43) evaluated the association between APOA2 SNPs and diabetes in Northern
European subjects. Although they did not find strong associations with diabetes, some
variants (including the promoter polymorphism) were significantly associated with 2-h
glucose and insulin secretion. However, none of these studies examined the potential
modulation by dietary fat. We observed a statistically significant interaction of the −265T>C
SNP with saturated fat intake in Chinese and Asian Indians. CC subjects had higher IR than
T-allele carriers only with a high-saturated fat consumption. Similarly, we observed a higher
OR for diabetes in the high-saturated fat strata (borderline significant). In the Mediterranean
population, the APOA2 SNP was not associated with diabetes risk in the whole population.
In the analysis stratified by saturated fat intake, we observed a higher prevalence of female
diabetic subjects in the low saturated fat strata. Taking into account the characteristics of our
high-risk Mediterranean population, in which the majority of individuals (>99%) with
diabetes were previously diagnosed by their physician before the inclusion in the study, this
observation could reflect a reverse causation situation due to dietary recommendations for
treating diabetes, this being a limitation of our study. In contrast, the Asian population was a
representative general population aged 18–69 years, in which a high percentage of
individuals with diabetes (>55% of total) were newly detected. However, in the Asian
population, the main limitation was the low prevalence of CC subjects in comparison with
Caucasian populations. This observation, apart from affecting the statistical significance of
the results, contributes to the fact that the population impact of this interaction in
determining obesity and IR in Asians in low.
In conclusion, despite some sample size limitations and population specific results, we have
replicated a gene-diet interaction involving the APOA2 −265T>C SNP and saturated fat
intake in determining body-weight in a Mediterranean and an Asian population, so
increasing the external validity of our previously reported results in American populations
(11). In addition, our results suggest that this interaction may also play a role in IR and
diabetes. However, prospective studies are required to better characterize this dietary
modulation.
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Figure 1.
Association between the APOA2 −265T>C polymorphism and body-weight in (A)
Mediterranean subjects (n= 374 TT, 398 TC and 135 CC) and in (B) Asian Indians (n= 305
TT, 160 TC and 29 CC). Adjusted means and error bars by genotype. Means were adjusted
for sex, age, tobacco smoking and alcohol consumption. * P values for mean comparison
between CC and T allele carriers obtained in the multivariate adjusted models. Error bars:
SE of means.
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Figure 2.
Interaction between the APOA2 −265T>C polymorphism and saturated fat intake on BMI in
(A) Mediterranean subjects (n=772 T-allele carriers and n= 135CC) and in (B) Chinese and
Asian Indians (n= 1483T-allele carriers and 28 CC sucjects). Adjusted means of BMI are
shown depending on the APOA2 −265T>C polymorphism according to the strata of
saturated fat intake (below and above 22g/d). Means were adjusted for sex, age (as
continuous), tobacco smoking (as categorical), alcohol consumption (as categorical),
diabetes status (as categorical), lipid medication (only in the Mediterranean population),
ethnicity (in the Asian population) and total energy intake (as continuous). P values for the
interaction terms between saturated fat intake (as dichotomous) and the APOA2
polymorphism in each population were obtained in the hierarchical multivariate interaction
model. In the stratified analysis by saturated fat intake levels, P values for mean
comparisons of BMI between APOA2 genotypes were estimated after multivariate
adjustment for the covariates indicated above. Bars indicate standard error (SE) of means.
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Figure 3.
Interaction between the APOA2 −265T>C polymorphism and saturated fat intake in
determining IR in Chinese (n=1204) and Asian Indians (n=307). Adjusted means of IR are
shown depending on the APOA2 −265T>C polymorphism (n=1493 T-allele carriers and 28
CC) according to the strata of saturated fat intake (below and above 22g/d). Means were
adjusted for sex, age (as continuous), ethnicity, tobacco smoking (as categorical), alcohol
consumption (as categorical), and total energy intake (as continuous). P values for the
interaction terms between saturated fat intake (as dichotomous) and the APOA2
polymorphism in each population were obtained in the hierarchical multivariate interaction
model. In the stratified analysis by saturated fat intake levels, P values for mean
comparisons of BMI between APOA2 genotypes were estimated after multivariate
adjustment for the covariates indicated above. All statistical analyses were carried out with
the ln transformed IR. Bars indicate standard error (SE) of means.
Corella et al. Page 14
Int J Obes (Lond). Author manuscript; available in PMC 2011 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Corella et al. Page 15
Table 1
General characteristics of the studied populations
Mediterranean Multiethnic Asian population
population (n=907) Chinese (n=2506) Malays (n=695) Asian Indians (n=494)
Mean SD Mean SD Mean SD Mean SD
Male/Female 325/582 1143/1363 335/360 236/258
Age (years) 67 (6) 38 (12) 39 (13) 40 (12)
Weight (kg) 77.5 (13.1) 60.5 (12.3) 65.8 (13.5) 66.4 (13.0)
BMI (Kg/m2) 30.9 (5.1) 22.7 (3.7) 25.6 (5.0) 25.1 (4.6)
Waist (cm) 104 (12) 78 (11) 83 (12) 85 (12)
HDL-C (mg/dL) 53.2 (14.1) 55.4 (14.8) 50.3 (12.9) 44.1 (11.3)
Fasting triglycerides (mg/dL) 130.9 (80.9) 124.6 (106.8) 148.6 (101.5) 151.3 (127.3)
Fasting glucose (mg/dL) 122.7 (40.2) 100.8 (23.4) 109.8 (37.8) 113.4 (39.6)
HOMA-IR ND 1.8 (1.3) 2.4 (2.2) 2.9 (2.8)
Energy intake (Kcal/d)* 2253 (669) 2045 (744) 2177 (931) 2220 (771)
Total fat intake (g/d)* 97.4 (32.9) 61.8 (29.3) 69.2 (39.5) 69.2 (29.3)
Total fat intake (% energy)* 39.1 (7.1) 26.6 (5.3) 27.9 (6.0) 27.7 (5.6)
Saturated fat intake (g/d)* 25.7 (10.0) 24.2 (12.7) 29.8 (17.8) 28.9 (15.2)
Saturated fat (% energy)* 10.2 (2.3) 10.3 (2.5) 11.8 (3.2) 11.4 (2.9)
Monounsaturated fat (% energy)* 19.2 (4.8) 9.2 (2.3) 9.0 (2.5) 8.1 (2.2)
Polyunsaturated fat (% energy)* 6.3 (2.3) 5.2 (2.0) 4.8 (2.0) 5.8 (2.6)
Saturated fat < 22g/d*; n (%) 362 (39.9) 614 (51.0) 165 (40.0) 115 (37.5)
Drinkers; n (%) 467 (51.5) 1132 (45.2) 55 (7.9) 162 (32.8)
Current smokers; n (%) 106 (11.7) 316 (12.6) 162 (23.3) 73 (14.8)
BMI>=30 Kg/m2 478 (52.7) 93 (3.7) 112 (16.1) 61 (12.3)
BMI>=27 Kg/m2 711 (78.4) 310 (12.4) 234 (33.7) 153 (31.0)
Diabetes; n (%) 443 (48.8) 182 (7.3) 103 (14.8) 97 (19.6)
Hypertension; n (%) 724 (79.8) 209 (8.3) 62 (8.9) 56 (11.3)
APOA2−265T>C genotype; n (%)
 TT 374 (41.2) 2080 (83.0) 558 (80.3) 305 (61.7)
 TC 398 (43.9) 405 (16.2) 128 (18.4) 160 (32.4)
 CC 135 (14.9) 21 (0.8) 9 (1.3) 29 (5.9)
*
Dietary variables were only determined in a random sample (1 in 2) of the Asian population (n=1,923 subjects: 1204 Chinese, 412 Malays and
307 Asian Indians)
HOMA-IR: Homeostasis model assessment of insulin resistance
ND: Not determined
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